<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-02479607</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-13T02:25:39+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1</title>
            <author role="aut">
              <persName>
                <forename type="first">C.</forename>
                <surname>Kouanfack</surname>
              </persName>
              <email type="md5">9c6ebf8478177b9d65743f9fcb21a137</email>
              <email type="domain">yahoo.fr</email>
              <idno type="idhal" notation="numeric">1300499</idno>
              <idno type="halauthorid" notation="string">1207421-1300499</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-0238-6205</idno>
              <idno type="VIAF">https://viaf.org/viaf/218548489</idno>
              <idno type="IDREF">https://www.idref.fr/147118360</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Mireille</forename>
                <surname>Mpoudi-Etame</surname>
              </persName>
              <idno type="halauthorid">1424524-0</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">P.</forename>
                <surname>Omgba Bassega</surname>
              </persName>
              <idno type="halauthorid">1793258-0</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">S.</forename>
                <surname>Eymard-Duvernay</surname>
              </persName>
              <email type="md5">6bc3f379c4bc92f46cfc0c7627c025ee</email>
              <email type="domain">ird.fr</email>
              <idno type="idhal" notation="string">seymardduvernay</idno>
              <idno type="idhal" notation="numeric">748815</idno>
              <idno type="halauthorid" notation="string">1344959-748815</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-6807-8192</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-67872"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">S.</forename>
                <surname>Leroy</surname>
              </persName>
              <idno type="halauthorid">657683-0</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">S.</forename>
                <surname>Boyer</surname>
              </persName>
              <idno type="halauthorid">84708-0</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Martine</forename>
                <surname>Peeters</surname>
              </persName>
              <email type="md5">ba73b9aef58230d37f4302323fd27c49</email>
              <email type="domain">mpl.ird.fr</email>
              <idno type="idhal" notation="numeric">1300500</idno>
              <idno type="halauthorid" notation="string">303078-1300500</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-6738-8730</idno>
              <idno type="IDREF">https://www.idref.fr/070149402</idno>
              <affiliation ref="#struct-1087128"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">A.</forename>
                <surname>Calmy</surname>
              </persName>
              <idno type="halauthorid">1448418-0</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">E.</forename>
                <surname>Delaporte</surname>
              </persName>
              <email type="md5">0a59547b1a2fddfd102adb35257028a0</email>
              <email type="domain">chu-montpellier.fr</email>
              <idno type="idhal" notation="numeric">791549</idno>
              <idno type="halauthorid" notation="string">363102-791549</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-1822-9853</idno>
              <idno type="IDREF">https://www.idref.fr/069236690</idno>
              <affiliation ref="#struct-1087128"/>
              <affiliation ref="#struct-303623"/>
            </author>
            <author role="ctb">
              <persName>
                <forename type="first">Avelin</forename>
                <surname>Aghokeng Fobang</surname>
              </persName>
              <email type="md5">a3d44f93c8c3ec7a06069f53f7444ccd</email>
              <email type="domain">ird.fr</email>
              <idno type="idhal" notation="string">avelin</idno>
              <idno type="idhal" notation="numeric">1371533</idno>
              <idno type="halauthorid" notation="string">3420674-1371533</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-1414-0237</idno>
              <idno type="IDREF">https://www.idref.fr/11023278X</idno>
              <affiliation ref="#struct-1004481"/>
              <affiliation ref="#struct-166573"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Mélisande</forename>
                <surname>Aiello</surname>
              </persName>
              <email type="md5">45c41c6420d0f1ee2f5ae96695cfd326</email>
              <email type="domain">umontpellier.fr.invalid</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2020-02-14 15:41:34</date>
              <date type="whenModified">2026-05-12 17:02:03</date>
              <date type="whenReleased">2020-02-19 14:25:48</date>
              <date type="whenProduced">2019</date>
              <date type="whenEndEmbargoed">2020-02-14</date>
              <ref type="file" target="https://hal.science/hal-02479607v1/document">
                <date notBefore="2020-02-14"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://hal.science/hal-02479607v1/file/nejmoa1904340.pdf" id="file-2479607-2360502">
                <date notBefore="2020-02-14"/>
              </ref>
              <ref type="externalLink" target="https://doi.org/10.1056/nejmoa1904340"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="700151">
                <persName>
                  <forename>Mélisande</forename>
                  <surname>Aiello</surname>
                </persName>
                <email type="md5">45c41c6420d0f1ee2f5ae96695cfd326</email>
                <email type="domain">umontpellier.fr.invalid</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-02479607</idno>
            <idno type="halUri">https://hal.science/hal-02479607</idno>
            <idno type="halBibtex">kouanfack:hal-02479607</idno>
            <idno type="halRefHtml">&lt;i&gt;New England Journal of Medicine&lt;/i&gt;, 2019, 381 (9), pp.816-826. &lt;a target="_blank" href="https://dx.doi.org/10.1056/NEJMoa1904340"&gt;&amp;#x27E8;10.1056/NEJMoa1904340&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">New England Journal of Medicine, 2019, 381 (9), pp.816-826. &amp;#x27E8;10.1056/NEJMoa1904340&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-2479607-2360502"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
            <idno type="stamp" n="IRD">IRD - Institut de recherche pour le développement</idno>
            <idno type="stamp" n="AFRIQ">HAL-Francophonie, Afrique et océan indien</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="AGROPOLIS">Agropolis</idno>
            <idno type="stamp" n="B3ESTE">Biologie, Ecologie, Evolution, Environnement, Sciences de la Terre et de l'Eau</idno>
            <idno type="stamp" n="BS">Biologie-Santé</idno>
            <idno type="stamp" n="UNIV-MONTPELLIER">Université de Montpellier</idno>
            <idno type="stamp" n="UM-2015-2021" corresp="UNIV-MONTPELLIER">Université de Montpellier (2015-2021)</idno>
            <idno type="stamp" n="TEST3-HALCNRS">TEST3-HALCNRS</idno>
            <idno type="stamp" n="TEST4-HALCNRS">collection test</idno>
            <idno type="stamp" n="INEE-CNRS">Institut écologie et environnement du CNRS</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1</title>
                <author role="aut">
                  <persName>
                    <forename type="first">C.</forename>
                    <surname>Kouanfack</surname>
                  </persName>
                  <email type="md5">9c6ebf8478177b9d65743f9fcb21a137</email>
                  <email type="domain">yahoo.fr</email>
                  <idno type="idhal" notation="numeric">1300499</idno>
                  <idno type="halauthorid" notation="string">1207421-1300499</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-0238-6205</idno>
                  <idno type="VIAF">https://viaf.org/viaf/218548489</idno>
                  <idno type="IDREF">https://www.idref.fr/147118360</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Mireille</forename>
                    <surname>Mpoudi-Etame</surname>
                  </persName>
                  <idno type="halauthorid">1424524-0</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">P.</forename>
                    <surname>Omgba Bassega</surname>
                  </persName>
                  <idno type="halauthorid">1793258-0</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">S.</forename>
                    <surname>Eymard-Duvernay</surname>
                  </persName>
                  <email type="md5">6bc3f379c4bc92f46cfc0c7627c025ee</email>
                  <email type="domain">ird.fr</email>
                  <idno type="idhal" notation="string">seymardduvernay</idno>
                  <idno type="idhal" notation="numeric">748815</idno>
                  <idno type="halauthorid" notation="string">1344959-748815</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-6807-8192</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-67872"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">S.</forename>
                    <surname>Leroy</surname>
                  </persName>
                  <idno type="halauthorid">657683-0</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">S.</forename>
                    <surname>Boyer</surname>
                  </persName>
                  <idno type="halauthorid">84708-0</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Martine</forename>
                    <surname>Peeters</surname>
                  </persName>
                  <email type="md5">ba73b9aef58230d37f4302323fd27c49</email>
                  <email type="domain">mpl.ird.fr</email>
                  <idno type="idhal" notation="numeric">1300500</idno>
                  <idno type="halauthorid" notation="string">303078-1300500</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-6738-8730</idno>
                  <idno type="IDREF">https://www.idref.fr/070149402</idno>
                  <affiliation ref="#struct-1087128"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">A.</forename>
                    <surname>Calmy</surname>
                  </persName>
                  <idno type="halauthorid">1448418-0</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">E.</forename>
                    <surname>Delaporte</surname>
                  </persName>
                  <email type="md5">0a59547b1a2fddfd102adb35257028a0</email>
                  <email type="domain">chu-montpellier.fr</email>
                  <idno type="idhal" notation="numeric">791549</idno>
                  <idno type="halauthorid" notation="string">363102-791549</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-1822-9853</idno>
                  <idno type="IDREF">https://www.idref.fr/069236690</idno>
                  <affiliation ref="#struct-1087128"/>
                  <affiliation ref="#struct-303623"/>
                </author>
                <author role="ctb">
                  <persName>
                    <forename type="first">Avelin</forename>
                    <surname>Aghokeng Fobang</surname>
                  </persName>
                  <email type="md5">a3d44f93c8c3ec7a06069f53f7444ccd</email>
                  <email type="domain">ird.fr</email>
                  <idno type="idhal" notation="string">avelin</idno>
                  <idno type="idhal" notation="numeric">1371533</idno>
                  <idno type="halauthorid" notation="string">3420674-1371533</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-1414-0237</idno>
                  <idno type="IDREF">https://www.idref.fr/11023278X</idno>
                  <affiliation ref="#struct-1004481"/>
                  <affiliation ref="#struct-166573"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">7381</idno>
                <idno type="issn">0028-4793</idno>
                <idno type="eissn">1533-4406</idno>
                <title level="j">New England Journal of Medicine</title>
                <imprint>
                  <publisher>Massachusetts Medical Society</publisher>
                  <biblScope unit="volume">381</biblScope>
                  <biblScope unit="issue">9</biblScope>
                  <biblScope unit="pp">816-826</biblScope>
                  <date type="datePub">2019</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1056/NEJMoa1904340</idno>
              <idno type="ird">fdi:010077283</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv.mhep.mi">Life Sciences [q-bio]/Human health and pathology/Infectious diseases</classCode>
              <classCode scheme="halDomain" n="sdv.sp.pharma">Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>BACKGROUND: An efavirenz-based regimen (with a 600-mg dose of efavirenz, known as EFV600) was the World Health Organization preferred first-line treatment for human immunodeficiency virus type 1 (HIV-1) infection until June 2018. Given concerns about side effects, dolutegravir-based and low-dose efavirenz-based combinations have been considered as first-line treatments for HIV-1 in resource-limited settings.METHODS: We conducted an open-label, multicenter, randomized, phase 3 noninferiority trial in Cameroon. Adults with HIV-1 infection who had not received antiretroviral therapy and had an HIV-1 RNA level (viral load) of at least 1000 copies per milliliter were randomly assigned to receive either dolutegravir or the reference treatment of low-dose efavirenz (a 400-mg dose, known as EFV400), combined with tenofovir and lamivudine. The primary end point was the proportion of participants with a viral load of less than 50 copies per milliliter at week 48, on the basis of the Food and Drug Administration snapshot algorithm. The difference between treatment groups was calculated, and noninferiority was tested with a margin of 10 percentage points.RESULTS: A total of 613 participants received at least one dose of the assigned regimen. At week 48, a viral load of less than 50 copies per milliliter was observed in 231 of 310 participants (74.5%) in the dolutegravir group and in 209 of 303 participants (69.0%) in the EFV400 group, with a difference of 5.5 percentage points (95% confidence interval [CI], -1.6 to 12.7; P&lt;0.001 for noninferiority). Among those with a baseline viral load of at least 100,000 copies per milliliter, a viral load of less than 50 copies per milliliter was observed in 137 of 207 participants (66.2%) in the dolutegravir group and in 123 of 200 participants (61.5%) in the EFV400 group, with a difference of 4.7 percentage points (95% CI, -4.6 to 14.0). Virologic failure (a viral load of &gt;1000 copies per milliliter) was observed in 3 participants in the dolutegravir group (with none acquiring drug-resistance mutations) and in 16 participants in the EFV400 group. More weight gain was observed in the dolutegravir group than in the EFV400 group (median weight gain, 5.0 kg vs. 3.0 kg; incidence of obesity, 12.3% vs. 5.4%).CONCLUSIONS: In HIV-1-infected adults in Cameroon, a dolutegravir-based regimen was noninferior to an EFV400-based reference regimen with regard to viral suppression at week 48. Among participants who had a viral load of at least 100,000 copies per milliliter when antiretroviral therapy was initiated, fewer participants than expected had viral suppression. (Funded by Unitaid and the French National Agency for AIDS Research; NAMSAL ANRS 12313 ClinicalTrials.gov number, NCT02777229.).</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-1087128" status="OLD">
          <idno type="ISNI">0000000403858088</idno>
          <idno type="RNSR">201119485L</idno>
          <idno type="ROR">https://ror.org/01ws78v34</idno>
          <orgName>Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes</orgName>
          <orgName type="acronym">TransVIHMI</orgName>
          <date type="start">2015-01-01</date>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>Centre IRD France Sud 911, avenue Agropolis BP 64501 F-34394 Montpellier cedex 5</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.umi233.com/</ref>
          </desc>
          <listRelation>
            <relation name="UMI 233" active="#struct-67872" type="direct"/>
            <relation active="#struct-217395" type="direct"/>
            <relation name="U 1175" active="#struct-303623" type="direct"/>
            <relation active="#struct-410122" type="direct"/>
            <relation active="#struct-1175215" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-67872" status="VALID">
          <idno type="IdRef">050165224</idno>
          <idno type="ROR">https://ror.org/05q3vnk25</idno>
          <orgName>Institut de Recherche pour le Développement</orgName>
          <orgName type="acronym">IRD</orgName>
          <desc>
            <address>
              <addrLine>SiègeLe Sextant 44, bd de DunkerqueCS 9000913572 Marseille cedex 02</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.ird.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-1004481" status="INCOMING">
          <orgName>Centre de recherches sur les maladies émergentes, ré-émergentes et la médecine nucléaire [Yaoundé, Cameroun]</orgName>
          <orgName type="acronym">CREMER</orgName>
          <desc>
            <address>
              <country key="CM"/>
            </address>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-166573" status="OLD">
          <idno type="IdRef">166407313</idno>
          <idno type="ISNI">0000000403823424</idno>
          <idno type="RNSR">201119437J</idno>
          <idno type="ROR">https://ror.org/00357kh21</idno>
          <orgName>Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle</orgName>
          <orgName type="acronym">MIVEGEC</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>911 Avenue Agropolis BP 64501 34394 Montpellier cedex 5</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://mivegec.fr/</ref>
          </desc>
          <listRelation>
            <relation name="UMR5290" active="#struct-410122" type="direct"/>
            <relation name="UMR5290" active="#struct-441569" type="direct"/>
            <relation name="224" active="#struct-451860" type="direct"/>
            <relation active="#struct-67872" type="indirect"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-217395" status="VALID">
          <idno type="ISNI">0000000121738504</idno>
          <idno type="ROR">https://ror.org/022zbs961</idno>
          <orgName>Université de Yaoundé I</orgName>
          <orgName type="acronym">UY1</orgName>
          <date type="start">1993-01-29</date>
          <desc>
            <address>
              <addrLine>B.P. 337 Yaoundé</addrLine>
              <country key="CM"/>
            </address>
            <ref type="url">https://uy1.uninet.cm/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-410122" status="OLD">
          <idno type="ISNI">0000000120970141</idno>
          <idno type="ROR">https://ror.org/051escj72</idno>
          <orgName>Université de Montpellier</orgName>
          <orgName type="acronym">UM</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>163 rue Auguste Broussonnet - 34090 Montpellier</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.umontpellier.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-1175215" status="VALID">
          <idno type="ROR">https://ror.org/04je6yw13</idno>
          <orgName>Université Cheikh Anta Diop de Dakar [Sénégal]</orgName>
          <orgName type="acronym">UCAD</orgName>
          <date type="start">1987-01-01</date>
          <desc>
            <address>
              <addrLine>Université Cheikh Anta Diop de Dakar - Rectorat, BP 5005 Dakar-fann</addrLine>
              <country key="SN"/>
            </address>
            <ref type="url">https://www.ucad.sn/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-451860" status="VALID">
          <orgName>Institut de Recherche pour le Développement - délégation Occitanie</orgName>
          <orgName type="acronym">IRD [Occitanie]</orgName>
          <desc>
            <address>
              <addrLine>911 avenue Agropolis,BP 6450134394 Montpellier cedex 5</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://occitanie.ird.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-67872" type="direct"/>
          </listRelation>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>